Search Results
Jun 27, 2026, 06:34 ET 273 International Students from 24 countries get degrees during annual convocation at Chandigarh University
https://mma.prnewswire.com/media/3001464/Press_Pic_001_INT_Convocation.jpg
More news about: Chandigarh University
Jun 22, 2026, 12:19 ET US WorldMeds® Receives Full U.S. FDA Approval of TECELRA® (afamitresgene autoleucel) with an Expanded Indication, Extending the First Approved Engineered T-Cell Therapy for a Solid Tumor to Children as Young as 12
Accessed May 15, 2026.3 Jami SA, Mobarak SA, Jiandang S, et al. Clinical and strategic outcomes of metastatic synovial sarcoma on limb. Int J Health Sci(Qassim). 2020;14:38–43.*Per Kaplan-Meier methodMedia ContactMaria LopesVP, Marketing &
More news about: US WorldMeds
Jun 22, 2026, 07:00 ET Boehringer Ingelheim accelerates precision oncology research with initiation of three Phase III trials in hard-to-treat cancers
27. doi:10.3389/fendo.2025.1635630Plaja A, et al. Small-Cell Lung Cancer Long-Term Survivor Patients : How to Find a Needle in a Haystack?. Int J Mol Sci. 2021;22(24):13508. Published 2021 Dec 16. doi:10.3390/ijms222413508Jeon H, Wang S, Song J, Gill H, Cheng H. Update 2025: Management
More news about: Boehringer Ingelheim
Jun 18, 2026, 09:00 ET bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
https://pmc.ncbi.nlm.nih.gov/articles/PMC10812683 - 8.Chlebicz A., Śliżewska K. Campylobacteriosis, salmonellosis, yersiniosis, and listeriosis as zoonotic foodborne diseases: A review. Int. J. Environ. Res. Public Health. 2018;15:863. doi: 10.3390/ijerph15050863.ABOUT BIOMÉRIEUXPioneering DiagnosticsA
More news about: bioMérieux
Jun 16, 2026, 10:45 ET Brain-healthy Habits for Men
https://doi.org/10.3390/nu141429865. Lokko P, Lartey A, Armar-Klemesu M, Mattes RD. Regular peanut consumption improves plasma lipid levels in healthy Ghanaians. Int J Food Sci Nutr. 2007;58(3):190–200. doi:10.1080/09637480701198067.6. Moreno JP, Mohammed A, Moore CE, Johnston C. Benefits of a snacking intervention
More news about: The Peanut Institute
Jun 10, 2026, 11:49 ET The Space Economy Just Got an On-Ramp to Wall Street
reported and subject to final pricing): https://capital.com/en-int/learn/ipo/spacex-ipo[4] Bloomberg — "How SpaceX's Dream of a Record-Breaking IPO Stacks Up" (raise reported up to ~$75B; valuation in the trillions;
More news about: Baystreet
Jun 10, 2026, 02:22 ET Lundbeck to present new patient data on neuroendocrine and neuroimmunology programs at ENDO 2026
Lancet. 2015;386(9996):913–927Sharma ST, Nieman LK, Feelders RA. Pituitary. 2015;18(2):188–194Ots HD, Tracz JA, Vinokuroff KE, et al. Int J Mol Sci. 2022;23(8):4115Dhaliwal NK, Razzaq L. Cureus. 2025;17(6):e86483.Lundbeck. Data on fileFeldhaus AL, et al. Endocrinology
More news about: H. Lundbeck A/S
Jun 10, 2026, 02:19 ET Lundbeck to present new patient data on neuroendocrine and neuroimmunology programs at ENDO 2026
Lancet. 2015;386(9996):913–927Sharma ST, Nieman LK, Feelders RA. Pituitary. 2015;18(2):188–194Ots HD, Tracz JA, Vinokuroff KE, et al. Int J Mol Sci. 2022;23(8):4115Dhaliwal NK, Razzaq L. Cureus. 2025;17(6):e86483.Lundbeck. Data on fileFeldhaus AL, et al. Endocrinology
More news about: H. Lundbeck A/S
Jun 09, 2026, 10:01 ET Alcohol-associated Liver Disease Market Gearing Up for Outstanding Expansion at a CAGR of 31.1% During the Forecast Period (2026-2036) | DelveInsight
ALD.Nterica's INT-787 is a next-generation oral farnesoid X receptor (FXR) agonist that was initially developed by Intercept Pharmaceuticals and later integrated into Alfasigma's liver disease portfolio following the company's 2023 acquisition. Through FXR activation, INT-787 is designed to
More news about: DelveInsight Business Research, LLP
Jun 05, 2026, 10:00 ET Eratrectinib, the next-generation TRK inhibitor independently developed by Vcare PharmaTech, has received marketing approval
Feb;11(2):355-372.Cocco E, et al. Nat Rev Clin Oncol. 2018 Dec;15(12):731-747.O'Haire S, et al. Sci Rep. 2023 Mar 13;13(1):4116.Qi C, et al. Int J Cancer. 2023 Dec 1;153(11):1916-1927.Vcare Pharma. Phase II Clinical Study Data of Eratrectinib[R]Commercial Cooperation:Strategic
More news about: Vcare PharmaTech
Jun 04, 2026, 08:00 ET HawkEye 360 Announces Two Key Leadership Appointments
company's continued growth and operational scale."Alex brings extraordinary systems engineering experience across space, airborne, and multi-INT domains, while EJ has played an instrumental role in building and advancing HawkEye 360's engineering foundation," said Todd Probert, Chief Operating
More news about: HawkEye 360 Inc.
Jun 03, 2026, 17:44 ET Red Bull Basement ayuda a emprendedores a convertir su idea en una empresa emergente financiada
para medios: redbull.com/int-en/events/red-bull-basement-world-final-2026Contacto para medios: [email protected]:
More news about: Red Bull
Jun 03, 2026, 13:45 ET Red Bull Basement hilft Gründern dabei, ihre Idee in ein finanziertes Start-up zu verwandeln
für Medien: redbull.com/int-de/events/red-bull-basement-world-final-2026Medienkontakt: [email protected]:
More news about: Red Bull
Jun 03, 2026, 13:41 ET Red Bull Basement aide les fondateurs à exploiter le potentiel de la programmation intuitive pour transformer leur idée en jeune pousse financée
médias : redbull.com/int-fr/events/red-bull-basement-world-final-2026Relations avec les médias : [email protected] :
More news about: Red Bull
Jun 03, 2026, 09:46 ET Axi 推出《Trading Triumphs》：輝煌背後，交易者榮獲 Axi Select 資助的故事
的故事揭開序幕。閱覽並收看閱覽完整網誌：https://www.axi.com/int/blog/company-news/axi-select-trading-triumphs-yoleny 收看 Yoleny 的故事：
More news about: AxiTrader LLC
Jun 03, 2026, 06:01 ET Axi lança "Trading Triumphs": As histórias dos traders que conquistaram o financiamento do Axi Select
https://www.axi.com/int/blog/company-news/axi-select-trading-triumphs-yoleny Assista à história de Yoleny:
More news about: AxiTrader LLC
Jun 03, 2026, 05:54 ET Axi lança "Trading Triumphs": As histórias dos traders que conquistaram o financiamento do Axi Select
https://www.axi.com/int/blog/company-news/axi-select-trading-triumphs-yoleny Assista à história de Yoleny:
More news about: AxiTrader LLC
Jun 03, 2026, 04:12 ET Red Bull Basement Is Helping Founders Vibe Code Their Idea Into a Funded Startup Reality
for media: redbull.com/int-en/events/red-bull-basement-world-final-2026Media Contact: [email protected]:
More news about: Red Bull
Jun 03, 2026, 04:10 ET Axi präsentiert Trading Triumphs: Die Geschichten hinter den Tradern, die sich ihre Axi Select-Finanzierung verdient haben
https://www.axi.com/int/blog/company-news/axi-select-trading-triumphs-yoleny Sehen Sie sich die Geschichte von Yoleny an:
More news about: AxiTrader LLC
Jun 03, 2026, 04:02 ET Axi、「Trading Triumphs」を開始：Axi Selectで資金提供を受ける権利を獲得したトレーダーたちの物語
記事を読む・動画を見るブログ記事全文を読む：https://www.axi.com/int/blog/company-news/axi-select-trading-triumphs-yolenyYolenyのストーリーを見る
More news about: AxiTrader LLC
Jun 03, 2026, 04:00 ET Red Bull Basement Is Helping Founders Vibe Code Their Idea Into a Funded Startup Reality
for media: redbull.com/int-en/events/red-bull-basement-world-final-2026Media Contact: [email protected]:
More news about: Red Bull
Jun 03, 2026, 03:58 ET 액시, Trading Triumphs 출시: Axi Select 펀딩 획득한 트레이더들의 비하인드 스토리
https://www.axi.com/int/blog/company-news/axi-select-trading-triumphs-yoleny욜레니의 이야기 보기:https://youtu.be/JTieJWQqrzA?si=qANS5rOlgL7EiidTAxi
More news about: AxiTrader LLC
Jun 02, 2026, 18:15 ET Axi lance « Trading Triumphs » : Les histoires des traders qui ont obtenu un financement Axi Select
https://www.axi.com/int/blog/company-news/axi-select-trading-triumphs-yoleny Regardez l'histoire de Yoleny :
More news about: AxiTrader LLC
Jun 02, 2026, 11:20 ET Axi presenta Trading Triumphs: los operadores que consiguieron financiación a través de Axi Select
https://www.axi.com/int/blog/company-news/axi-select-trading-triumphs-yolenyVea la historia de Yoleny:
More news about: AxiTrader LLC
Jun 02, 2026, 07:18 ET Axi Launches Trading Triumphs: The Stories Behind the Traders Who Earned Their Axi Select Funding
https://www.axi.com/int/blog/company-news/axi-select-trading-triumphs-yoleny Watch Yoleny's story:
More news about: AxiTrader LLC